| Drug Name: | Gemfibrozil (25812-30-0) |
|---|---|
| PubChem ID: | 3463 |
| SMILES: | CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O |
| InchiKey: | HEMJJKBWTPKOJG-UHFFFAOYSA-N |
| Therapeutic Category: | Antimetabolites, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Enzyme Inhibitors, Hypolipidemic Agents, Lipid Regulating Agents |
| Molecular Weight (dalton) | : | 250.338 |
| LogP | : | 3.57324 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 46.53 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Carbamazepine (298-46-4) | Ataxia | Synergistic | uncertain | Therapeutic drug monitoring—antiepileptic drugs |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category